&nbsp;

obsp-7-22-24.xml

Jul 2024

Document

obsp-7-22-24.html

Jul 2024

Document

CAR-T-cell-Therapy-Clinical-Trials-Funding-Policy.pdf

Jul 2024

Chimeric Antigen Receptor (CAR) T-cell Therapy Clinical Trials Funding Policy

Document

OntarioCancerProfilesProjectionsAppendix.xlsx

Aug 2024

Regimen

CISPGEMC+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

CRBPGEMC+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

CISPPEME+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

CRBPPEME+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2025

Document

OBSP-Digital-Breast-Tomosynthesis-Report-Template-with-breast-implants.pdf

Sep 2024

Document